Evaluation of cryoablation therapy for lung cancer

Hu xiao-bo,Cao Jian-min,Xu Jian,Chen Bo,Lu Guang-ming

DOI: https://doi.org/10.3969/j.issn.1009-4393.2010.11.017

2010-01-01

Abstract:Objective To discuss the efficacy and clinical significance of the Cryoablation treatment of lung cancer. Methods 68 patients were divided into 3 groups by the diameter of the tumor (<3cm,3～5cm,<5cm),accepted the Argon-helium cryoablation operation respectively,and were dealt with Routine hemostasis and anti-inflammatory treatment after the operation. Four weeks later,each patient was followed up by CT and DSA,and the clinical effect was assessed by the change of the CT value in the tumor area,the RECIST criterion and the Survival statistics. All statistical data were analyzed by SPSS13.0 software mainly through the paired t-test and x2 test. Difference were considered to be statistically significant if P<0.05. The Long-rank method was applied to get the median survival time and draw the survival curves. Results The coverage of the spherical frozen region in 68 patients was above 90% after the operation,and the overall efficiency judged by the RECIST criterion was 82.35%. The CT value of the frozen area was 42.09±8.03Hu before the operation and -7.13±8.25Hu after it. The CT value had significant difference during each groups(P<0.01).The assessment of the RECIST before and after the cryoablation was not statistically significant. The overall assessment of the RECIST 6 months after the operation was 82.35%.In addition,42 of 68 patients died during the follow-up and the median survival time of the 68 patients was 13 months. Conclusion Cryoablation has the virtue of minimally invasive and safety and the evaluation methods of the CT value change and RECIST are meaningful for the assessment of the clinical effect of cryoablation.